When stratifying hrHPV-positive women into two age groups, there was a borderline non-significant difference in CIN3+ risk (adjusted for non-attendance at repeat testing) between women ⩾34 years of age and women invited for the first time (aged 29–33 years) (relative risk (RR) 0.78 95% CI: 0.52–1.15).
← all excerpts
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
1
—
—